Health Care & Life Sciences » Biotechnology | PTC Therapeutics Inc.

PTC Therapeutics Inc.

PTC Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.21 M
Public Float
38.91 M
PTC Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.52
Market Cap
$2.58 B
Shares Outstanding
58.43 M
Public Float
55.51 M

Profile

Address
100 Corporate Court
South Plainfield New Jersey 07080
United States
Employees -
Website http://www.ptcbio.com
Updated 07/08/2019
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders.

Financials

View All
Created with Highcharts 5.0.14PTC Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.48 18248 18293 75393 753170 447170 447142 110142 11079 00079 000128 081128 081201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14PTC Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.34 69634 69625 24525 24536 76636 76682 70582 705194 392194 392264 734264 734201320142015201620172018050k100k150k200k250k300k

Stuart W. Peltz
Chief Executive Officer & Director
Michael Schmertzler
Chairman